KIT D816V
|
AML
|
KIT D816V
|
AML
|
dasatinib Sensitive: C3 – Early Trials
|
dasatinib Sensitive: C3 – Early Trials
|
KIT D816V
|
AML
|
KIT D816V
|
AML
|
YD312 Resistant: D – Preclinical
|
YD312 Resistant: D – Preclinical
|
KIT D816V
|
Mast Cell Leukemia
|
KIT D816V
|
Mast Cell Leukemia
|
abemaciclib Sensitive: D – Preclinical
|
abemaciclib Sensitive: D – Preclinical
|
KIT D816V
|
Mast Cell Leukemia
|
KIT D816V
|
Mast Cell Leukemia
|
palbociclib Sensitive: D – Preclinical
|
palbociclib Sensitive: D – Preclinical
|
KIT D816V
|
Mast Cell Leukemia
|
KIT D816V
|
Mast Cell Leukemia
|
ribociclib Sensitive: D – Preclinical
|
ribociclib Sensitive: D – Preclinical
|